Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2018 | 03-2018 | 12-2017 | 12-2016 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 0 | 315 | 0 |
| Other current assets | 0 | 0 | 130 | 0 |
| TOTAL | $0 | $0 | $445 | $0 |
| Non-Current Assets | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $0 | $0 | $445 | $0 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 97 | 0 |
| Accrued Expenses | 0 | 0 | 1,169 | 0 |
| TOTAL | $0 | $0 | $1,266 | $0 |
| Non-Current Liabilities | ||||
| Long Term Debt | 0 | 0 | 40 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 6,001 | 0 |
| TOTAL | $N/A | $N/A | $6,041 | $N/A |
| Total Liabilities | $0 | $0 | $7,307 | $0 |
| Shareholders' Equity | ||||
| Retained earnings | 0 | 0 | -6,894 | 0 |
| TOTAL | $0 | $0 | $-6,862 | $0 |
| Total Liabilities And Equity | $0 | $0 | $445 | $0 |